期刊名称 journal of translational medicine
期刊缩写 J TRANSL MED
学科分类 医学、生命科学
出版周期 不详
审稿速度 1个月 （平均）
投稿命中率 50%（均值)
期刊主页 http://www.translational-medicine.com/
ISSN 号 1479-5876
IF 趋势 2005 2006 2007 2008 2009 2010 2011 2012
0 0 2.935 2.917 3.407 3.508 3.474 3.459
被收录情况 1. Science Citation Index Expanded
2. Current Contents - Clinical Medicine
PubSci评语 开放期刊，必须缴纳2090美元费用。审稿慢，给钱后基本一周内发表。审稿专家比较专业，编辑比较Nice。文章需要有临床大样本数据，还需要一些体外机制数据。
期刊简介 该刊是一个开放期刊，主要关注转化医学领域，期刊可以分为以下几个部分：癌症微环境，心血管、代谢及脂蛋白翻译，细胞、组织和基因治疗、临床翻译、组合策略、计算模型和流行病学、疾病生物标记物、免疫学和免疫治疗、免疫病毒学、医学生物信息学、神经科学、营养与代谢、病人靶向的分子治疗及个性化医学。
投稿注意事项 特别提醒：该刊是开放期刊，所有接受的论文必须缴纳1290英镑或2090美元或1545欧元费用，低收入国家的作者可费用减免。
一般注意事项：
About Journal of Translational Medicine
Aims and scope | Open access | Article-processing charges | Indexing services |Publication and peer review process | Editorial policies |Citing articles in Journal of Translational Medicine |Why publish your article in Journal of Translational Medicine?
This page includes information about the aims and scope of Journal of Translational Medicine, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Aims & scope
Journal of Translational Medicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science.
The journal covers all areas of translational medicine but also has several special sections:
Cancer microenvironment - Edited by Fernando Vidal-Vanaclocha
Cardiovascular, Metabolic and Lipoprotein Translation- Edited by Nehal N. Mehta
Cell, tissue and gene therapy - Edited by David Stroncek
Clinical translation - Edited by George Coukos
Combination strategies - Edited by Paolo A. Ascierto
Computational modeling and epidemiology- Edited by Michael Liebman and Sabrina Molinaro
Disease biomarkers - Edited by Xiangdong Wang
Immunobiology and immunotherapy - Edited by Adrian Bot
Immunovirology - Edited by Luigi Buonaguro
Medical Bioinformatics - Edited by Samir K. Brahmachari
Neuroscience - Edited by Luis F. Alguacil
Nutrition & metabolism - Edited by Laura Soldati
Patient-targeted molecular therapies - Edited by Francesco Chiappelli
Personalised medicine - Edited by Lotfi Chouchane (Qatar Foundation, Weill Cornell Medical College)
Open access
All articles published by Journal of Translational Medicine are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
Authors of articles published in Journal of Translational Medicine are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Article-processing charges
Open access publishing is not without costs. Journal of Translational Medicine therefore levies an article-processing charge of £1290/$2090/€1545 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.
Indexing services
All articles published in Journal of Translational Medicine are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Journal of Translational Medicine include:
CAS
Citebase
Current contents
DOAJ
Embase
EmCare
Google Scholar
Index Copernicus
MEDLINE
OAIster
PubMed
PubMed Central
Science Citation Index Expanded
SCImago
Scirus
Scopus
SOCOLAR
Zetoc
The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives includinge-Depot (The Netherlands).
Journal of Translational Medicine is tracked by Thomson Reuters (ISI) and has an Impact Factor of 3.46.
Publication and peer review process
Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Journal of Translational Medicine, a personalized section of the site.
Reprints
High-quality, bound reprints can be purchased for all articles published. Please see ourreprints website for further information about ordering reprints.
Supplements
Journal of Translational Medicine will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.
Editorial policies
All manuscripts submitted to JTM should adhere to BioMed Central's editorial policies.
Citing articles in Journal of Translational Medicine
Articles in Journal of Translational Medicine should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. J Transl Med [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. J Transl Med 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Why publish your article in Journal of Translational Medicine?
High visibility
Journal of Translational Medicine's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.
Speed of publication
Journal of Translational Medicine offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles are published with their final citation immediately upon acceptance in a provisional PDF form. The article will subsequently be published in both fully browsable web form, and as a formatted PDF; the article will then be available through Journal of Translational Medicine, BioMed Central and PubMed Central and will also be included in PubMed.
Flexibility
Online publication in Journal of Translational Medicine gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Journal of Translational Medicine are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Journal of Translational Medicine's pages and on the BioMed Central homepage.
In addition, articles published in Journal of Translational Medicine may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Journal of Translational Medicine. A list of articles recently press-released by journals published by BioMed Central is available here.
Copyright
Authors of articles published in Journal of Translational Medicine retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see theBioMed Central copyright and license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.
编辑部信息 所在地： 国家 卡塔尔
Editor-in-Chief
Dr Francesco Marincola Sidra Medical and Research Center, Qatar
Deputy Editors
Dr Christian Brander Irsicaixa AIDS Research Institute, Spain
Dr Graham Pawelec University of Tubingen Medical School, Germany
Dr Ena Wang NIH, United States of America
Senior Editors
Gennaro Ciliberto National Cancer Institute Fondazione G. Pascale, Napoli, Italy
Dr Soldano Ferrone Hillman Cancer Center, United States of America
Dr Willy Flegel National Institutes of Health, United States of America
Dr Monica C. Panelli University of Pittsburgh Cancer Institute, United States of America
Dr Doug Schwartzentruber Indiana University Health, United States of America
Section Editors
Cancer microenvironment
Prof Fernando Vidal-Vanaclocha CEU-San Pablo University School of Medicine, Spain
Cardiovascular, Metabolic and Lipoprotein Translation
Dr Nehal Mehta National Heart, Lung and Blood Institute, United States of America
Cell, tissue and gene therapy
Dr David Stroncek National Institutes of Health, United States of America
Clinical translation
Dr George Coukos University of Pennsylvania, United States of America
Combination strategies
Dr Paolo A. Ascierto Istituto Nazionale Tumori Fondazione G. Pascale, Italy
Computational Modelling and Epidemiology
Dr Michael Liebman Strategic Medicine, Inc, United States of America
Dr Sabrina Molinaro National Research Council, Italy
Disease Biomarkers
Prof Xiangdong Wang Lund University, Sweden
Immunobiology and immunotherapy section
Dr Adrian Bot Kite Pharma Inc, United States of America
Immunovirology
Dr Luigi Buonaguro National Cancer Institute, Italy
Medical bioinformatics
Prof Samir Brahmachari Institute of Genomics & Integrative Biology, India
Neuroscience
Dr Luis F. Alguacil Hospital General Ciudad Real, Spain
Nutrition & metabolism
Dr Laura Soldati Università degli Studi di Milano, Italy
Patient-targeted molecular therapies
Dr Adrian Bot Kite Pharma Inc, United States of America
Dr Francesco Chiappelli University of California, Los Angeles, USA
Personalized medicine
Prof Lotfi Chouchane Weill Cornell Medical College in Qatar, Qatar
Associate Editors
Dr Stefan Ambs National Cancer Institute, United States of America
Dr Davide Bedognetti National Institutes of Health, United States of America
Dr Damien Chaussabel Benaroya Research Institute at Virginia Mason, United States of America
Dr Maurizio Chiriva-Internati Texas Tech University Health Sciences Center, United States of America
Dr Giovanni Cizza National Institute of Diabetes and Digestive and Kidney Diseases, United States of America
Dr Ralph S. Freedman The University of Texas MD Anderson Cancer Center, United States of America
Professor Sebastiano Gattoni-Celli Medical University of South Carolina, United States of America
Dr Lotta Kristina Gustafsson Lund University, Sweden
Dr Stephen Hewitt National Cancer Institute, United States of America
Dr Markus Hinder Novartis Institute for BioMedical Research, Switzerland
Professor Dongming Hou Saint Joseph's Hospital of Atlanta, United States of America
Dr Thomas ichim Medistem Inc., San Diego, CA, United States of America
Dr Giuseppe Intini Harvard School of Dental Medicine, United States of America
Professor W. Martin Kast University of Southern California, United States of America
Dr Howard Kaufman Columbia University, United States of America
Gottfried Koehler University of Vienna, Austria
Dr Razelle Kurzrock The University of Texas MD Anderson Cancer Center, United States of America
Dr Maciej Lesniak The University of Chicago, United States of America
Dr Steven Libutti National Cancer Institute, United States of America
Dr Paolo Lusso NIAID, NIH, United States of America
Dr James Lyons-Weiler University of Pittsburgh Cancer Institute, United States of America
Professor Pier Giorgio Natali Regina Elena Cancer Institute, Italy
Dr Hideho Okada University of Pittsburgh, United States of America
Dr Elizabeth A. Repasky Roswell Park Cancer Institute, United States of America
Professor Noriyuki Sato Sapporo Medical University School of Medicine, Japan
Dr Aamir Shahzad University of Vienna, Austria
Dr Laura Soldati Università degli Studi di Milano, Italy
Dr Craig Webb Van Andel Research Institute, United States of America
Dr Qian Xie Van Andel Research Institute, United States of America
Professor Chunxiang (Kevin) Zhang New Jersey Medical School, United States of America
Combination strategies
Dr Howard Streicher National Cancer Institute, United States of America
Immunobiology and immunotherapy section
Dr Adrian Bot Kite Pharma Inc, United States of America
Immunovirology
Dr Pierre Coursaget INSERM, France
Dr Quentin Sattentau Oxford University, United Kingdom
Patient-targeted molecular therapies
Dr Adrian Bot Kite Pharma Inc, United States of America
网友投稿经验整理：
SCI(2010)：3.51
比较快，从网上递交到修回接收1个半月，审稿专家比较专业，编辑比较nice。美中不足是发表费用2000多美金。文章需要有临床大样本数据，还需一些体外机制研究数据。
贡献者： smilesusu
审稿时间:约1个月 接收率：约50% SCI(2011)：3.47
我们最近发表述评一篇，供参考。
Title: A global resource to translational medicine: the International Park of Translational Medicine and BioMedicine (IPTBM)
Authors: Wu Xiaodan, Marincola M Francesco, Liebman N Michael, Wang Xiangdong,
URL: http://www.translational-medicine.com/content/11/1/8
要抓住国外研究的重点和热点。
贡献者：WXD
审稿有点慢（近6个月，中间修稿一次1个月），但接受后出版非常快，5个工作日就完成。
贡献者：cx
审稿加修改用了3个月。这个杂志就是审稿慢，但是一给了钱就在1周内发表。
贡献者：
研究方向：重症医学 审稿时间:约1个月 接收率：约50%
投稿后一个半月左右就收到两位专家的审稿意见，根据审稿意见修改后（花了两周时间修改），一个月之内就收到交版面费的通知。然后就一周时间发表了。前后不到五个月。
贡献者：117.88.227.70
